Skip to main content
. 2017 Sep 30;8(54):92522–92535. doi: 10.18632/oncotarget.21439

Figure 3. Subgroup analysis for prognostic value of red blood cell distribution width (RDW) for overall survival (OS).

Figure 3

Kaplan–Meier plots for patients who received CHOP or CHOP-like (A) and non-CHOP or CHOP-like (P-Gemox or LVD or VDLP) (B) regimen according to RDW<46.2 fL versus RDW>46.2 fL.